I help medtech and semiconductor innovators detect patent and regulatory risks early—so R&D stays on track, investments stay protected, and product launches don’t get derailed by late surprises. Through IPvera, I combine patent analytics, FDA/EMA regulatory insight, and market intelligence to provide clear, actionable guidance during the most critical phases of innovation. My focus is on identifying system-level risks that traditional patent searches or regulatory reviews often miss—especially in biosensors, diagnostics, and emerging semiconductor technologies. How I help: • Early risk scans for new technologies • Prior art assessment & novelty analysis • Patent landscape and system-level FTO • Patent–regulatory mapping (FDA + EMA) • Competitive intelligence dashboards • Strategic IP reports for investors and M&A Why you should work with me: • Deep technical background in biosensors, diagnostics, and semiconductor systems • Experience across R&D, tech transfer, and commercialization • Integration of IP + regulatory + market signals into one coherent strategy • Deliverables designed for decision-makers, not attorneys If you’re planning a new device, exploring a market, preparing for investment, or facing uncertainty about IP or regulatory pathways, I’d be happy to discuss how IPvera can support you.
| Website | https://ipvera.com/ |
| Employees | 1 (0 on RocketReach) |
| Founded | 2025 |
| Industry | Research Services |
Looking for a particular IPvera employee's phone or email?
IPvera is based in Berlin, Berlin.